Your search results are below. For a different search, enter another term below and click on the "Search" button:
-
321. 10,000+ deaths likely result of pandemic screening delays, more reports predict
... Jan. 28. The researchers examined screening rates for colorectal cancer and breast cancer during the COVID-19 pandemic. Richard Bold, MD, physician-in-charge at UC Davis Comprehensive Cancer Center, ...29 January 2021 -
322. The ASC market's revenues, Dr. Farid Namin's PPE manufacturer and more — 4 GI industry not
... procurement obstacles early in the pandemic. 4. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test. More ...27 January 2021 -
323. Trump pardons CEO of controversial pain practice, Optum's plans to grows & more — 8 ASC industry note
... a Jan. 20 earnings call. Read more. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced ...26 January 2021 -
324. At-home options boost CRC screening rates, study finds
A study of Kaiser Permanente members in Southern California found that offering patients to self-order a colorectal cancer screening test online increases rates of test completion, according to a Jan. ...21 January 2021 -
325. CMS declines to reimburse for 1st FDA-approved blood-based CRC screening test
The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced Jan. 21. Epigenomics AG will ...21 January 2021 -
326. Liquid biopsy test detected patients at risk for CRC relapse
A liquid biopsy test that detects circulating tumor DNA identified patients likely to redevelop colorectal cancer after having undergone surgery to remove tumors, Medpage Today reported Jan. 17. Researchers ...19 January 2021 -
327. Exact Sciences' $58B bet on diagnostic screening & 4 other updates from the company's busy wee
... in three diagnostic screening markets: colorectal cancer screening, multi-cancer screening, and minimal residual disease and recurrence monitoring. The three markets represent a combined $58 billion market. ...15 January 2021 -
328. CRC blood tests, partnerships and more — 4 GI industry notes
... novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study. A developer is building ...13 January 2021 -
329. New blood test detects CRC advanced adenomas, study says
Freenome's novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study. Researchers ...12 January 2021 -
330. 10 changes CMS made in 2021
... procedure. CMS increased the percent physicians are reimbursed by 41 percent. 10. Created a guideline for in-development blood-based colorectal cancer screening tests to earn approval. More articles ...07 January 2021 -
331. Patients with family history of CRC may be able to follow regular screening recommendations
Patients with a family history of colorectal cancer that had a negative screening colonoscopy may be able to wait 10 years for their next exam, according to a study submitted to 2020 Digestive Disease ...06 January 2021 -
332. Pill-based colonoscopy prep launched in US
... FDA approval in over 10 years. Alan Cooke, president and CEO of Sebela Pharmaceuticals, said the company designed the pill to encourage more patients to get screened for colorectal cancer. Traditional ...05 January 2021 -
333. 28 things to know about USPI, SCA, AmSurg and Surgery Partners
... the U.S. Preventive Services Task Force proposed guidance to lower the recommended colorectal cancer screening age to 45, Jay Popp, MD, AmSurg medical staff lead, spoke to Becker's ASC Review about how ...05 January 2021 -
334. Florida colorectal surgeon opens office with Tenet Florida Physician Services
Leandro Feo, MD, joined Tenet Florida Physician Services to open an office in Boca Raton, according to South Florida Hospital News and Healthcare Report. Dr. Feo previously practiced at South Palm ...04 January 2021 -
335. Exact Sciences: 2020 in review
... tests in 2019. March: Donates money to Fight Colorectal Cancer to launch the Catalyst State-by-State Advocacy Program. The program funds efforts to advance legislation that promotes CRC screening. ...30 December 2020 -
336. CRH Medical to lose client, GI studies — 3 GI industry notes
... from certain ethnic groups with colorectal cancer may be unable to access follow-up care, according to a study published in Cancer. New York City-based Mount Sinai researchers built risk scores that ...30 December 2020 -
337. GI in 2021 — What 6 gastroenterologists think is in store for the specialty
... more risk as part of a value proposition; this was in its nascency but derailed as part of the crisis. GI practices that are truly forward thinking will expand to include colorectal and laparoscopic surgeons, ...28 December 2020 -
338. What ASC execs need to know about the COVID-19 relief bill: 6 details
... by 3.75 percent next year. 5. Cost sharing for colorectal cancer screening of Medicare beneficiaries would be phased out between January 2022 and January 2030 under the bill. 6. The law requires patients ...28 December 2020 -
339. Follow-up CRC care affected by disparities
Patients from certain ethnic groups with colorectal cancer may be unable to access follow-up care, according to a study published in Cancer. Cure reported on the study Dec. 28. Researchers reviewed ...28 December 2020 -
340. The loophole is closing — Congress includes colonoscopy loophole bill in COVID-19 relief package
The Removing Barriers to Colorectal Cancer Screening Act of 2020 passed the U.S. House Dec. 9 and was included in the COVID-19 relief bill the Senate cleared Dec. 21. If the bill is signed into law, ...22 December 2020